Merit Medical proposes $550M convertible senior notes offering due 2029

MERIT MEDICAL SYSTEMS INC

Proposed $550M aggregate principal amount of 2029 convertible senior notes; initial purchasers may buy additional $82.5M.
Net proceeds to fund capped call transactions, repay debt, general corporate purposes including R&D and potential acquisitions.
Notes will be senior unsecured obligations; interest rate and conversion terms to be set at pricing.
Company expects to enter capped call transactions to reduce potential dilution upon conversion.
Offering only to QIBs under Rule 144A; notes not registered under Securities Act.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.